Concurrent Session 2C - Part 1: Prescribed Drugs | Part 2: Improving Service Users Experience & Engagement
Tracks
Track 3
Wednesday, October 30, 2024 |
3:30 PM - 5:00 PM |
Menzies |
Details
Chair: Kate Senior, DASSA
Speaker
Prof Suzanne Nielsen
Professor And Deputy Director, Monash Addiction Research Centre
Monash University
An e-Delphi study to develop best-practices for opioid safety in community pharmacy settings
3:30 PM - 3:40 PMBiography
Professor Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is the Deputy Director of the Monash Addiction Research Centre at Monash University in Melbourne. She has been a registered pharmacist for over 20 years, with clinical experience in the treatment of substance use disorders in community pharmacy and specialist drug treatment settings.
Ms Amy McNeilage
PhD Candidate
The University of Sydney
Lived experiences of nonmedical gabapentinoid use and symptoms of dependence: A systematic review of qualitative research
3:40 PM - 3:45 PMBiography
Amy McNeilage is PhD Candidate and Senior Research Officer at The University of Sydney studying gabapentinoid-related harms. She has developed expertise in qualitative methodology and has demonstrated the quality of her research with publications in several leading journals, including IJDP, PAIN, & IJDP.
Dr Ria Hopkins
Postdoctoral Research Fellow
National Drug And Alcohol Research Centre, UNSW Sydney
“We didn’t cause the opioid epidemic”: The experiences of Australians prescribed opioids for chronic non-cancer pain at a time of increasing restrictions.
3:45 PM - 3:55 PMBiography
Dr Ria Hopkins is a Postdoctoral Research Fellow at the National Drug and Alcohol Research Centre, UNSW Sydney, examining patterns of medicine use and associated outcomes. She is interested in potentially high-risk medicines including opioid and psychotropic medicines, and priority populations including people living with pain or mental health conditions.
Dr Ting Xia
Research Fellow
Monash University
Geographic variation in gabapentinoid, opioid and physical therapies utilisation among injured workers with low back pain
3:55 PM - 4:00 PMBiography
Dr Ting Xia is a Research Fellow with Monash Addiction Research Centre at Monash University with a focus on the use of linked primary health data and hospital data to evaluate the impact of policy changes on opioid prescribing.
Dr Hester Wilson
Phd Student And Doctor
Drug and Alcohol Services, South East Sydney Local Health District
General practitioner experiences diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in NSW, Australia, 2021–2023
4:00 PM - 4:10 PMBiography
Dr Hester Wilson, FRACGP, FAChAM, is a GP, Clinical Director of Drug and Alcohol in Murrumbidgee Local Health District, Medical Advisor for South East Sydney Local Health District, chair of Addiction SIG in the RACGP, PhD candidate and conjoint senior lecturer at UNSW and Chief Addiction Medicine Specialist for NSW.
APSAD 2024
Session Q&A
4:10 PM - 4:20 PMBiography
Ms Chloe Haynes
Phd Student/Research Assistant
University of Wollongong
A scoping review of women’s experiences of treatment for opioid use disorder through a person-centred care lens
4:20 PM - 4:25 PMBiography
Ms. Haynes is a PhD Candidate at the University of Wollongong and is conducting research on women's experiences of treatment for opioid use disorder, particularly their experiences of person-centred care. She has been engaged in numerous other research projects through her work as a research assistant.
Ms Grace Shuttleworth
Clinical Research And Program Content Lead
Lives Lived Well
Enhancing consumer engagement through digital innovation in mental health and substance use services
4:25 PM - 4:30 PMBiography
Grace Shuttleworth is a Clinical Psychologist, currently employed by Lives Lived Well as the Clinical Research and Program Content Lead. Grace has worked across residential, community, hospital and correctional facilities, providing support for substance use concerns. Past research has focused on the effective integration lived-experience approaches in clinical services.
Dr Shelley Walker
DECRA Research Fellow
National Drug Research Institute
“It felt like they were doing everything they could to find [drugs]”: Policing experiences of people who use drugs during the COVID-19 pandemic
4:30 PM - 4:40 PMBiography
Shelley is a Research Fellow at the Melbourne office of the National Drug Research Institute. She is a recipient of an ARC Discovery Early Career Research Award about police custody and young people, and is passionate about social justice and human rights issues.
James Poole
Principles for collaborative partnerships with people with lived or living experience in research projects
4:40 PM - 4:45 PMBiography
Ms Anke van der Sterren
Deputy CEO
Alcohol Tobacco and Other Drug Association ACT
Principles for collaborative partnerships with people with lived or living experience in research projects
4:40 PM - 4:45 PMBiography
Anke is the Deputy CEO at the Alcohol Tobacco and Other Drug Association ACT (ATODA). Anke is a social scientist with over 25 years’ experience in research and evaluation in the areas of alcohol and other drugs, tobacco, blood borne viruses and workforce development.
APSAD 2024
Session Q&A
4:45 PM - 5:00 PMBiography
Chair
Katherine Senior
Addiction Medicine Specialist
DASSA